132 related articles for article (PubMed ID: 25339068)
1. Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression.
Zhao X; Sun B; Sun D; Liu T; Che N; Gu Q; Dong X; Li R; Liu Y; Li J
Oncol Rep; 2015 Jan; 33(1):149-56. PubMed ID: 25339068
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
3. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
6. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.
Sun C; Sun L; Jiang K; Gao DM; Kang XN; Wang C; Zhang S; Huang S; Qin X; Li Y; Liu YK
Int J Biochem Cell Biol; 2013 Jun; 45(6):1099-108. PubMed ID: 23474366
[TBL] [Abstract][Full Text] [Related]
7. Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells.
Guo JC; Yang YJ; Zheng JF; Zhang JQ; Guo M; Yang X; Jiang XL; Xiang L; Li Y; Ping H; Zhuo L
Exp Mol Med; 2019 Nov; 51(11):1-20. PubMed ID: 31757938
[TBL] [Abstract][Full Text] [Related]
8. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
9. TALEN-induced disruption of Nanog expression results in reduced proliferation, invasiveness and migration, increased chemosensitivity and reversal of EMT in HepG2 cells.
Yu AQ; Ding Y; Li CL; Yang Y; Yan SR; Li DS
Oncol Rep; 2016 Mar; 35(3):1657-63. PubMed ID: 26676719
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repressor snail and progression of human hepatocellular carcinoma.
Sugimachi K; Tanaka S; Kameyama T; Taguchi K; Aishima S; Shimada M; Sugimachi K; Tsuneyoshi M
Clin Cancer Res; 2003 Jul; 9(7):2657-64. PubMed ID: 12855644
[TBL] [Abstract][Full Text] [Related]
12. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract][Full Text] [Related]
13. Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug.
Sun C; Sun L; Li Y; Kang X; Zhang S; Liu Y
Med Oncol; 2013 Jun; 30(2):503. PubMed ID: 23430442
[TBL] [Abstract][Full Text] [Related]
14. Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines.
Chu WK; Dai PM; Li HL; Pao CC; Chen JK
Carcinogenesis; 2013 Jul; 34(7):1497-509. PubMed ID: 23536578
[TBL] [Abstract][Full Text] [Related]
15. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
16. [Analysis on the expression of the stem cells related genes in hepatocellular carcinoma cell lines].
Zou C; Yuan FJ; Zhou WB; Huang L; Wang J; Zhang YS
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):599-602. PubMed ID: 19719918
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
[TBL] [Abstract][Full Text] [Related]
18. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
[TBL] [Abstract][Full Text] [Related]
19. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
[TBL] [Abstract][Full Text] [Related]
20. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]